Cargando…

Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants

IMPORTANCE: Practice variability exists in the use of corticosteroids to treat or prevent bronchopulmonary dysplasia in extremely preterm infants, but there is limited information on longer-term impacts. OBJECTIVE: To describe the use of corticosteroids in extremely preterm infants and evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puia-Dumitrescu, Mihai, Wood, Thomas R., Comstock, Bryan A., Law, Janessa B., German, Kendell, Perez, Krystle M., Gogcu, Semsa, Mayock, Dennis E., Heagerty, Patrick J., Juul, Sandra E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917427/ https://www.ncbi.nlm.nih.gov/pubmed/35275165 http://dx.doi.org/10.1001/jamanetworkopen.2022.1947

Ejemplares similares

Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2021)

Predicting 2-year neurodevelopmental outcomes in extremely preterm infants using graphical network and machine learning approaches
por: Juul, Sandra E., et al.
Publicado: (2022)

Contemporary Definitions of Infant Growth Failure and Neurodevelopmental and Behavioral Outcomes in Extremely Premature Infants at Two Years of Age
por: Strobel, Katie, et al.
Publicado: (2023)

Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
por: Juul, Sandra E., et al.
Publicado: (2022)

Patterns of Infections among Extremely Preterm Infants
por: Perez, Krystle, et al.
Publicado: (2023)

Time to Regain Birthweight and Association with Neurodevelopmental Outcomes among Extremely Preterm Newborns
por: Valentine, Gregory, et al.
Publicado: (2023)

Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial
por: Wood, Thomas R., et al.
Publicado: (2021)

Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
por: Vu, Phuong T., et al.
Publicado: (2021)

Diffusion Tensor Imaging Changes Do Not Affect Long-Term Neurodevelopment following Early Erythropoietin among Extremely Preterm Infants in the Preterm Erythropoietin Neuroprotection Trial
por: Law, Janessa B., et al.
Publicado: (2021)

Dexamethasone/methylprednisolone/prednisolone: Psychosis: case report
Publicado: (2021)

Neuroprotective potential of erythropoietin in neonates; design of a randomized trial
por: Juul, Sandra E., et al.
Publicado: (2015)

Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial
por: Juul, Sandra E., et al.
Publicado: (2023)

Dexamethasone/methylprednisolone/prednisolone: Avascular necrosis following off-label use:3 case reports
Publicado: (2021)

Methylprednisolone/prednisolone: Pneumothorax: case report
Publicado: (2020)

Iron and Neurodevelopment in Preterm Infants: A Narrative Review
por: German, Kendell R., et al.
Publicado: (2021)

Dexamethasone/methylprednisolone/prednisolone: Rhino-orbital-cerebral mucormycosis and off-label use: 5 case reports
Publicado: (2021)

Methylprednisolone/prednisolone: Lack of efficacy: case report
Publicado: (2022)

Cyclophosphamide/methylprednisolone/prednisolone: Multiple infections: case report
Publicado: (2021)

Methylprednisolone/prednisolone/azathioprine: Various toxicities: case report
Publicado: (2021)

Treatment for hypotension in the first 24 postnatal hours and the risk of hearing loss among extremely low birth weight infants
por: Gogcu, Semsa, et al.
Publicado: (2020)

Methylprednisolone/prednisolone: Prolongation of the lung injury healing: case report
Publicado: (2022)

Corticosteroids in chronic inflammatory demyelinating polyneuropathy: A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone
por: van Lieverloo, G. G. A., et al.
Publicado: (2018)

Methylprednisolone/pembrolizumab/prednisolone: Various toxicities and lack of efficacy: case report
Publicado: (2021)

Methylprednisolone/prednisolone/ruxolitinib: Masked fever and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022)

Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone
por: Fappi, Alan, et al.
Publicado: (2019)

Dexamethasone/methylprednisolone: Various toxicities: case report
Publicado: (2022)

Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report
Publicado: (2021)

Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with vasculitis of rheumatic disease
por: Rouster-Stevens, KA, et al.
Publicado: (2005)

Methylprednisolone/prednisolone: Masking of COVID-19 infection followed by its reactivation: case report
Publicado: (2021)

Methylprednisolone/prednisolone: Delayed viral clearance and off label use: 2 case reports
Publicado: (2020)

Methylprednisolone/prednisolone/tozinameran: Idiopathic inflammatory myopathy and lack of efficacy: 2 case reports
Publicado: (2022)

Methylprednisolone/moxifloxacin/prednisolone: Lack of efficacy and off-label use: 2 case reports
Publicado: (2021)

Use of Dexmedetomidine and Opioids in Hospitalized Preterm Infants
por: Curtis, Samantha, et al.
Publicado: (2023)

Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm
por: Qin, Gordon, et al.
Publicado: (2017)

Dexamethasone/methylprednisolone: Various toxicities: 2 case reports
Publicado: (2020)

Dexamethasone/methylprednisolone/steroids: Hypertension: 2 case reports
Publicado: (2021)

Baricitinib/methylprednisolone/prednisolone: Elevated HBV DNA following an off label use: case report
Publicado: (2022)

Intravenous Methylprednisolone Versus Oral Prednisolone for West Syndrome: A Randomized Open-Label Trial
por: Kapoor, Dipti, et al.
Publicado: (2021)

Azd-1222/methylprednisolone/prednisolone: Longitudinal extensive transverse myelitis and lack of efficacy: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u6tvo1ri82lvb924nmfi6duu8o